Advances in BRAF-targeted therapies for non-small cell lung cancer: the promise of encorafenib and binimetinib

被引：0
|
作者：
Fareed, Areeba [1 ]
Amir, Nabiha [1 ]
Ajaz, Humna [2 ]
Sohail, Afra [1 ]
Vaid, Rayyan [1 ]
Farhat, Solay [3 ]
机构：
[1] Karachi Med & Dent Coll, Dept Med, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
[3] Lebanese Univ, Fac Med Sci, Beirut, Lebanon
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2024年 / 110卷 / 04期
关键词：
OPEN-LABEL; DABRAFENIB;
D O I：
10.1097/JS9.0000000000001051
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1891 / 1893
页数：3
相关论文
共 50 条
  • [21] How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer?
    Coate, Linda E.
    Leighl, Natasha B.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2011, 12 (01) : 1 - 11
  • [22] Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer
    Halliday, Patrick R.
    Blakely, Collin M.
    Bivona, Trever G.
    CURRENT ONCOLOGY REPORTS, 2019, 21 (03)
  • [23] MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview
    Tibaldi, Carmelo
    D'Incecco, Armida
    Lagana, Alessandro
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (06) : 694 - 700
  • [24] Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape
    Pal, Sumanta Kumar
    Figlin, Robert A.
    Reckamp, Karen
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) : 1931 - 1944
  • [25] New Targeted Therapies for Metastatic Non-Small Cell Lung Cancer
    Riely, Gregory J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22
  • [26] Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies
    Berghmans, Thierry
    Cadranel, Jacques
    Grigoriu, Bogdan
    FRONTIERS IN MEDICINE, 2021, 8
  • [27] Targeted therapies for treatment of non-small cell lung cancer-Recent advances and future perspectives
    Minguet, Joan
    Smith, Katherine H.
    Bramlage, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (11) : 2549 - 2561
  • [28] Recent advances in targeted therapy for non-small cell lung cancer
    Ramalingam, Suresh
    Belani, Chandra P.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) : 245 - 257
  • [29] A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
    Riely, Gregory J.
    Smit, Egbert F.
    Ahn, Myung-Ju
    Felip, Enriqueta
    Ramalingam, Suresh S.
    Tsao, Anne
    Johnson, Melissa
    Gelsomino, Francesco
    Esper, Raymond
    Nadal, Ernest
    Offin, Michael
    Provencio, Mariano
    Clarke, Jeffrey
    Hussein, Maen
    Otterson, Gregory A.
    Dagogo-Jack, Ibiayi
    Goldman, Jonathan W.
    Morgensztern, Daniel
    Alcasid, Ann
    Usari, Tiziana
    Wissel, Paul
    Wilner, Keith
    Pathan, Nuzhat
    Tonkovyd, Svitlana
    Johnson, Bruce E.
    FUTURE ONCOLOGY, 2024, 20 (16) : 1047 - 1055
  • [30] Treatment of non-small cell lung cancer and targeted therapies: where are we?
    Gridelli, C
    Rossi, A
    Malone, P
    CURRENT OPINION IN ONCOLOGY, 2005, 17 (02) : 114 - 117
12345